BLUE CROSS BLUE SHIELD UPDATE
Magellan Rx went live July 1st.
As many of you know, Blue Cross Blue Shield of Alabama launched a new partnership with Magellan Rx effective July 1, 2019. Magellan Rx will be replacing Prime Therapeutics for the Provide- Administered Drug Review Program. The AGS/BCBS Committee was invited to meet with BCBS and Magellan, along with many other interested physicians and administrators, to learn about the changes. The meeting was for educational purposes and to ask questions in a collaborative effort to ensure the there were few issues moving forward with the new procedure. It was stated in the meeting that if any groups have issues with tis new procedure and would like to share, please email us at firstname.lastname@example.org. Below is the link to the webinar offered by BCBS on the transition to Magellan RX.